- Home
- TRGP vs BSX Comparison
TRGP vs BSX Comparison
Compare TRGP & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRGP | BSX |
|---|---|---|
| Founded | 2005 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.7B | 68.0B |
| IPO Year | 2010 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TRGP | BSX |
|---|---|---|
| Price | $287.58 | $42.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 31 |
| Target Price | ★ $325.95 | $59.90 |
| AVG Volume (30 Days) | 1.0M | ★ 17.5M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | 47.91 | ★ 55.20 |
| EPS | ★ 5.75 | 1.51 |
| Revenue | ★ $17,028,300,000.00 | $9,076,000,000.00 |
| Revenue This Year | $11.47 | $5.56 |
| Revenue Next Year | $25.79 | $4.77 |
| P/E Ratio | $50.17 | ★ $27.84 |
| Revenue Growth | 3.95 | ★ 12.49 |
| 52 Week Low | $144.14 | $41.39 |
| 52 Week High | $307.94 | $105.65 |
Technical Indicators
Market Signals| Indicator | TRGP | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 54.42 | 38.87 |
| Support Level | $284.00 | N/A |
| Resistance Level | $295.72 | $46.06 |
| Average True Range (ATR) | 7.02 | 0.98 |
| MACD | 0.77 | -0.04 |
| Stochastic Oscillator | 78.32 | 23.31 |
Price Performance
Historical ComparisonAbout TRGP Targa Resources Inc.
Targa Resources Corp is a midstream firm that mainly operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset. It has two operating segments: Gathering and Processing, and, Logistics and Transportation (also referred to as the Downstream Business).
About BSX Boston Scientific Corporation
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.